Announcements Trials

Browse Landscape

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 8 Breast Neoplasms 6 Prostatic Neoplasms 5 Triple Negative Breast Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Small Cell Lung Carcinoma 2 Prostatic Neoplasms, Castration-Resistant 2 Lung Neoplasms 2 Glioma 2 Glioblastoma 2 Uterine Cervical Neoplasms 1 Solid Tumor 1 Sarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 Neoplasm, Residual 1 Metastatic Castration-sensitive Prostate Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Endometrial Neoplasms 1 Disease Progression 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Neuroendocrine 1

Interventions

pembrolizumab 3 zimberelimab 1 tilsotolimod 1 sintilimab 1 sacituzumab govitecan 1 niraparib 1 encorafenib 1 cobimetinib 1 cedazuridine 1 binimetinib 1 atezolizumab 1 Radiosurgery 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Everolimus 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Solid Tumor × niraparib × Clear all

NCT04185831 2024-08-22

MEGALiT

Uppsala University Hospital

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡